Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4696108013 | Calamine and zinc oxide only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4696109017 | Product containing only calamine and zinc oxide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Calamine and zinc oxide only product in cutaneous dose form | Is a | Calamine- and zinc oxide-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Calamine and zinc oxide only product in cutaneous dose form | Is a | Calamine and zinc oxide only product | true | Inferred relationship | Some | ||
| Calamine and zinc oxide only product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Calamine and zinc oxide only product in cutaneous dose form | Has active ingredient | Calamine (substance) | true | Inferred relationship | Some | 1 | |
| Calamine and zinc oxide only product in cutaneous dose form | Has active ingredient | Zinc oxide | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Is a | True | Calamine and zinc oxide only product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR